ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (215 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.pharmthera.2005.08.009    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2005 Elsevier Inc. All rights reserved.

Associate editor: P.S. Foster

Clues to asthma pathogenesis from microarray expression studies

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael S. RolphCorresponding Author Contact Information, E-mail The Corresponding Author, Mary Sisavanh, Sue M. Liu and Charles R. Mackay

Arthritis and Inflammation Research Program, Garvan Institute for Medical Research, Darlinghurst, Australia

CRC for Asthma, University of Sydney, Camperdown, Australia


Available online 3 October 2005.

Abstract

Asthma is a chronic inflammatory disease characterized by airway hyperresponsiveness (AHR), tissue remodeling, and airflow obstruction. The pathogenesis of asthma is only partly understood, and there is an urgent need for improved therapeutic strategies for this disease. Microarray technology has considerable promise as a tool for discovery of novel asthma therapeutic targets, although the field is still in its infancy. A number of studies have described expression profiles derived from human asthmatic lung tissue, mouse airway tissue, or from key cell types associated with asthma, but to date relatively few studies have exploited these findings to discover new pathways involved in the pathogenesis of asthma. Among the genes to have been identified by array studies and validated by further studies are monokine induced by interferon (IFN)-γ, fatty acid binding proteins (FABP), and complement factor 5 (C5). Here we provide examples of microarray approaches to the discovery of new molecules associated with asthma. We anticipate that these types of analyses will provide considerable insight into asthma pathogenesis and will provide a wealth of new molecules for downstream analyses such as gene deficient mouse studies, or monoclonal antibody production.

Keywords: Asthma; Microarray; Mast cell; Bronchial epithelium; Cytokine

Abbreviations: AHR, airway hyperresponsiveness; FABP, fatty acid binding protein; GM-CSF, granulocyte-macrophage colony stimulating factor; HBE, human bronchial epithelial cells; IFN, interferon; IL, interleukin; MBP, major basic protein; STAT, signal transducer and activator of transcription

Article Outline

1. Introduction
1.1. Etiology and pathogenesis of asthma
1.2. Asthma therapies
1.3. Functional genomics
2. Profiling asthmatic tissue
2.1. Human studies
2.2. Animal models
2.3. Considerations relating to tissue profiling studies
2.3.1. Source of tissue
2.3.2. Ongoing therapy
2.3.3. Tissue heterogeneity
2.3.4. Addressing the challenges of profiling tissue samples
3. Profiling purified and cultured cells
3.1. Mast cells
3.2. Airway epithelial cells
3.3. Airway smooth muscle cells
3.4. Th1/Th2 cells
3.5. Eosinophils
3.6. Integrating array data from multiple cell types
4. Conclusion
Acknowledgements
References



Corresponding Author Contact InformationCorresponding author. Arthritis and Inflammation Research Program, Garvan Institute for Medical Research, 384 Victoria Street, Darlinghurst NSW 2010, Australia. Tel.: +61 2 92958351.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.